

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hiv infections | D015658 | EFO_0000764 | B20 | — | — | — | — | 3 | 3 |
| Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | — | — | — | — | 3 | 3 |
| Immunologic deficiency syndromes | D007153 | — | D84.9 | — | — | — | — | 1 | 1 |
| Aids-related complex | D000386 | EFO_0007137 | B20 | — | — | — | — | 1 | 1 |
| Drug common name | Alovudine |
| INN | alovudine |
| Description | Alovudine is a pyrimidine 2',3'-dideoxyribonucleoside. |
| Classification | Small molecule |
| Drug class | antineoplastics; antivirals (zidovudine group) (exception: edoxudine) |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | Cc1cn([C@H]2C[C@H](F)[C@@H](CO)O2)c(=O)[nH]c1=O |
| PDB | — |
| CAS-ID | 25526-93-6 |
| RxCUI | — |
| ChEMBL ID | CHEMBL105318 |
| ChEBI ID | — |
| PubChem CID | 33039 |
| DrugBank | DB06198 |
| UNII ID | PG53R0DWDQ (ChemIDplus, GSRS) |
